tirzepatide glp-1 gip vs. Semaglutide: What You Should Know 1+GIP — tailored just to you. Special Offer Tirzepatide - 3-month

Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward to maintenance doses ranging from 5 mg to 15 mg weekly, depending on individual tolerance and response

Phentermine/topiramate (Qsymia) Qsymia has phentermine and topiramate as its active ingredients

Reported side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain or bloating Indigestion (GERD) Heartburn Excessive burping Gas or flatulence Fatigue Headache Dizziness Lightheadedness Hair thinning Injection site pain, redness, or swelling Loss of appetite Acid reflux Cold sweats Dry mouth Metallic taste in mouth Mild rash Trouble concentrating Restlessness or jitteriness Unusual tiredness Some patients may experience severe nausea , especially during the first few weeks

Combining tirzepatide with intermittent fasting or very-low-calorie diets multiplies the risk

For a detailed comparison, see our guide on tirzepatide expiration

This item is also available for pre-order